EXPERT PERSPECTIVES ON TIMELY SYSTEMIC TREATMENT OF PLAQUE PSORIASIS
The deep impact of mild plaque psoriasis
Addressing potential challenges with topical use
Is it more than just joint pain? Early signs of PsA
Treating plaque psoriasis beyond the skin: the need for earlier systemic treatment
Each of the speakers was compensated by Amgen for their participation in the program
Program Objectives
Discuss how limited skin involvement impacts treatment decisions in plaque PsO and why patients may consider it more than just “mild”
Review the potential challenges associated with traditional and novel topical therapy use in PsO
Discuss the prevalence of PsA in patients with PsO, factors that increase the risk of PsA in patients with PsO, and how the risk of PsA can factor into treatment decisions
Highlight how the manifestations of PsO contribute to treatment considerations and discuss how timely treatment with systemic therapies may be beneficial to appropriate patients
Meet the Speakers
MODERATOR
Shawn G. Kwatra, MD
Associate Professor, Department of
Dermatology and Oncology
Johns Hopkins University
Director, Johns Hopkins Itch Center
Baltimore, Maryland
G. Michael Lewitt, MD, FAAD
Dermatology Physician and Partner
Illinois Dermatology Institute – The Chicago Loop
Director of Medical Dermatology Research
Denova Research dba Arno LLC
Chicago, Illinois
Saakshi Khattri, MBBS, MD, FAAD, FACR
Assistant Professor
Director, Center to Treat
Connective Tissue Diseases
The Kimberly and Eric Waldman
Department of Dermatology Icahn
School of Medicine at Mount Sinai
New York, NY
© 2023 Amgen Inc. All rights reserved.
10/23 USA-407-83299